Business · 25/06/2021Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Prescription Drug Marketing Review
Summary
The Food and Drug Administration is seeking public comment on a proposed collection of information related to prescription drug marketing, which has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →